Kao Chin Ngeow

Title: Innovations of Kao Chin Ngeow in Genomic Detection

Introduction

Kao Chin Ngeow is a prominent inventor based in Singapore, known for his contributions to the field of genomic research. He has developed innovative methods that enhance the detection and quantification of genomic and gene expression alterations. His work is crucial for advancing our understanding of genetic variations and their implications in biological samples.

Latest Patents

Kao Chin Ngeow holds a patent for a method of detecting and quantifying genomic and gene expression alterations using RNA. This patent outlines a comprehensive approach that includes determining the presence or absence of genomic alterations and quantifying gene expression levels. The method involves variant calling from sequence alignments, identifying differences between consensus reads and reference genomes, and determining read counts of sequence alignments that contain genomic alterations. The alterations can include insertions, deletions, and single nucleotide variants. Additionally, he has developed a kit for detecting and quantifying these alterations in biological samples.

Career Highlights

Kao Chin Ngeow is associated with Lucence Life Sciences Pte Ltd., where he applies his expertise in genomic research. His work at Lucence Life Sciences focuses on innovative solutions for genomic analysis, contributing to advancements in personalized medicine and diagnostics.

Collaborations

Some of his notable coworkers include Yukti Choudhury and Chae Yin Cher, who collaborate with him on various projects within the company.

Conclusion

Kao Chin Ngeow's innovative methods in genomic detection represent significant advancements in the field of genetic research. His contributions are vital for improving diagnostic techniques and understanding genetic variations.